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Type I and Type II Diabetes Mellitus: Pathophysiology and Nursing Anesthesia Considerations
Megan Przybysz, BSN, RN, CCRN, CFRN
Otterbein University, Westerville, Ohio
General Pathophysiology

Introduction
Diabetes Mellitus (DM) is a group of
metabolic diseases “resulting from
defects in insulin secretion, insulin
action, or both “(McCance, 2014, p. 734).
•

22 Million people in the USA have
DM (Pontes et al., 2017)

•

10-25% of people with DM don’t
know it (Cornelius, 2016)

•

•

•
•

7th leading cause of death in the US
(Cornelius, 2016)

•

$245 Billion in national healthcare
costs (Cornelius, 2016)

•

DM is the most common medical
condition and 25% of diabetics will
need surgery at some point
(Moningi et al., 2018)

•

Risk Factors

•
•

+

Age greater than 45
Hypertension
Obesity (90% DM patients are
obese) (Cornelius, 2016)
Sedentary lifestyle
Familial history
(Pontes et al., 2017)
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•
•
•
•
•

Polyuria
Polydipsia
Weight loss
Diabetic Ketoacidosis (DKA) (DM I
only)
Nocturia
Hunger
Blurred Vision
Dry skin
Slow Healing wounds
(McGinlay & Mruthunjaya, 2017; CDC,
2021)

•

•
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•

Autoantigens expressed on
pancreatic islet cells which activate
T helper lymphocytes.
Activation leads to inflammatory
cytokine secretion
Autoimmune destruction of
pancreatic Beta cells in the Islet of
Langerhans (McGinlay &
Mruthunjaya, 2017)

•

Pancreatic dysfunction due to
“glycotoxicity, lipotoxicity and
amyloid formation” (Pontes et al.,
2017)
Insulin resistance leads to insufficient
of defective insulin secretion
(McGinlay & Mruthunjaya, 2017)
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Figure 2: Type I vs. Type II Diabetes (Horber et al., 2019)

Autonomic Neuropathy (AN)
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•
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Figure 1: Pathophysiology and Complications of Diabetes (Skyler et al., 2017)

•

Present in approximately 20% of DM
patients (Cornelius, 2016)
“Glycosylation of endoneurial blood
vessels may cause neural hypoxia,
resulting in the dysfunction of the
autonomic nerves of the heart”
leading to increased risk if silent
ischemia (Cornelius, 2016)
AN can lead to the loss of autonomic
responses to hypoglycemia (the
patient will not show classic signs
and symptoms of hypoglycemia)
(Pontes et al., 2017)

Significance of
Pathophysiology
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Type I Diabetes

In states of chronic hyperglycemia,
glucose combines with free fatty acids.
Accumulation of these glycation end
products can lead to microvascular
complications. (McGinlay & Mruthunjaya,
2017)
•
Microangiopathic: endothelial
hyperplasia and thickened capillary
basement membranes lead to
vasoconstriction and hypoxia,
eventually leading to retinopathy,
nephropathy, neuropathy, etc.
•
Macroangiopathic: atherosclerosis
and increased risk of blood clots
(Moningi et al., 2018)

Environment
( e.g., viruses, microbiome,
physical activity, dietary factors)

Genes

DM I decreases life expectancy by
20 years, DMII by 10 years
(Cornelius, 2016)

Because of the prevalence of DM in the
US, it is imperative that the Nurse
Anesthetist is knowledgeable about the
pathophysiology of DM and how that
may affect anesthetic care.

•
•
•

DM is result of the inability of the
body to properly metabolize fats,
proteins and carbohydrates, as a
result of insufficient insulin or the
inability to utilize insulin
(Cornelius, 2016)
Lack of insulin leads to
glycogenesis and glycogenolysis by
the liver, as well as a reduced
uptake of glucose. (Levitsky, p.47,
2021)
DM is often seen as a part of
metabolic syndrome: increased
triglycerides, insulin resistance,
obesity, hypertension and
hyperlipidemia (Levitsky, 2021)

AN affecting the vagus nerve causes:
1.
Unopposed sympathetic nervous
system (SNS) response leading to
tachycardia
2.
Impaired SNS response to cardiac
output
3.
Neurogenic bladder/ erectile
dysfunction
4.
Anemia from decreased
erythropoietin production
5.
Gastroparesis
(Cornelius, 2016; Moningi et al., 2018)

Only 14% of DM pts have no
comorbidities (Cornelius, 2016)
•
Comorbidities: obesity,
cardiovascular disorders,
hypertension, hyperlipidemia,
chronic kidney disease (CKD),
depression, sleep disorders,
increased cancer risk (Cornelius,
2016)
Cardiovascular:
•
Major cause of death in DM, 10x
increase in death if heart rate over
105bpm for over 5 minutes in the
postoperative period (Cornelius,
2016)
•
Increased risk of hypertension,
coronary artery disease, CHF, silent
myocardial ischemia, and
peripheral vascular disease
(McGinlay & Mruthunjaya, 2017)
•
Hyperglycemic states lead to
“prothrombotic, proinflammatory,
proatherogenic state and impairs
vasodilation” (Pontes, et al, 2017)
Nephropathy:
•
CKD present in 40% of DM patients
(Cornelius, 2016)
•
CKD leads to anemia, platelet
dysfunction and albuminuria
(Pones et al., 2017)
Hepatic
.
•
Fatty liver disease is closely related
to DM and obesity, leading to the
development of non-alcoholic
chronic liver disease and
hepatocellular cancers (McGinlay &
Mruthunjaya, 2017)
•
Liver disease is one of the primary
causes of death in DMII (Cornelius,
2016)
•
Increased incidence of hepatitis B/C
and hemochromatosis (Cornelius,
2016)
Immune System:
•
DM I has 15% increased incidence
of other autoimmune disorders
(Pontes et al., 2017)
•
Increased risk of hypothyroid, celiac
disease, myasthenia gravis, and
adrenal insufficiency (McGinlay &
Mruthunjaya, 2017)
Peripheral:
•
Peripheral neuropathy
•
Stiff joint Syndrome: “glycosylation
of proteins and abnormal collage
cross linking in joint” as a result of
chronic hyperglycemia (Pontes et
al., 2017)

Implications for
General Nursing Care

•

•

•
•
•

•

Decreased GI motility and
increased gastric volumes
from chronic hyperglycemia
increase risk of vomiting and
aspiration (Pontes et al.,
2017)
IV starts may be difficult due
to diabetic scleroderma
(Cornelius, 2016)
Impaired blood flow may
lead to delayed wound
healing (Moningi et al., 2018)
DMI patients MUST receive
insulin to meet basal
metabolic needs and prevent
ketoacidosis (Pontes et al.,
2017)
NSAIDs/COX inhibitors
decrease renal blood flow
and may cause edema. Can
cause acute renal failure or
electrolyte imbalances
(Pontes et al., 2017)

Implications for
Anesthetic Care
•

•

•

•

•
1.
2.
3.

Perioperative mortality is 50%
higher with DM and more likely for
perioperative
complications(reintubation, longer
post operative ventilator time, need
for resuscitation (Pontes et al.,
2017)
Hyperglycemia can cause intra/post
operative:DKA, wound
infections/delayed healing, HHNK
(Cornelius, 2016)
Increased susceptibility to nerve
injuries: increased risk with
peripheral nerve blocks and
vascular damage at block site
(Moningi, 2018)
Stiff neck syndrome can cause
reduced mobility in the cervical
spine, leading to increased
difficulties in intubation (Pontes et
al., 2017)
Anesthesia can affect blood glucose
via SNS tone: (Pontes et al., 2017)
GABA agonists reduce cortisol
secretion
Clonidine reduces SNS and NE
release
Inhaled anesthetics inhibit insulin

Conclusions
•

•

•

The decision to place a
patient with DM under
general anesthesia should
not be taken lightly.
There are many facets to
consider
Discussions between the
surgeon, anesthesia
provider and the patient
are paramount to discuss
acceptable blood glucose
both before and during
surgery.
The successful
management of DM and
any complications allow
for the best surgical
outcome for the patient,
not only the perioperative
period, but also their postsurgical recovery
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